[Federal Register Volume 65, Number 175 (Friday, September 8, 2000)]
[Notices]
[Pages 54537-54538]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-23137]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Care Financing Administration

[HCFA-3036-N]


Medicare Program; Meeting of the Medical and Surgical Procedures 
Panel of the Medicare Coverage Advisory Committee--October 17 and 18, 
2000

AGENCY: Health Care Financing Administration (HCFA), HHS.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: This notice announces a public meeting of the Medical and 
Surgical Procedures Panel of the Medicare Coverage Advisory Committee 
(MCAC). The panel provides advice and recommendations to the agency 
about clinical issues. The panel will hear and discuss presentations 
from interested persons regarding electrostimulation for the treatment 
of wounds and sacral nerve stimulation for the treatment of refractory 
urinary urge incontinence and refractory urgency-frequency syndrome. 
Notice of this meeting is given under the Federal Advisory Committee 
Act (5 U.S.C. App. 2, section 10(a)(1) and (a)(2)).

DATES:   
    The Meeting: The meeting will be held on October 17, 2000 from 8 
a.m. until 4 p.m., and on October 18, 2000 from 8 a.m. until 2:30 p.m. 
E.D.T.
    Deadline for Presentations and Comments: September 26, 2000, 5 
p.m., E.D.T.
    Special Accommodations: Persons attending the meeting who are 
hearing or visually impaired, and have a condition that requires 
special assistance or accommodations, are asked to notify the Executive 
Secretary by September 19, 2000.

ADDRESSES:   
    The Meeting: The meeting will be held at the Baltimore Convention 
Center, Room 327, One West Pratt Street, Baltimore, MD 21201.
    Presentations and Comments: Submit formal presentations and written 
comments to Constance A. Conrad, Executive Secretary; Office of 
Clinical Standards and Quality; Health Care Financing Administration; 
7500 Security Boulevard; Mail Stop S3-02-01; Baltimore, MD 21244.

[[Page 54538]]

    Website: You may access up-to-date information on this meeting at 
www.hcfa.gov/quality/8b.htm.
    Hotline: You may access up-to-date information on this meeting on 
the HCFA Advisory Committee Information Hotline, 1-877-449-5699 (toll 
free) or in the Baltimore area (410) 786-9379.

FOR FURTHER INFORMATION CONTACT: Constance A. Conrad, Executive 
Secretary, 410-786-4631.

SUPPLEMENTARY INFORMATION: On August 13, 1999, we published a notice 
(64 FR 44231) to describe the MCAC, which provides advice and 
recommendations to us about clinical issues. This notice announces the 
following public meeting of the MCAC.

Current Panel Members

    Alan M. Garber, M.D.; Michael D.Maves, M.D.; Angus M. McBryde, 
M.D.; H.Logan Holtgrewe, M.D.; Arnold M. Epstein, M.D., Kenneth P. 
Brin, M.D.; Les J. Zendle, M.D.; Bruce Sigsbee, M.D.; James P. 
Rathmell, M.D.; Phyllis E. Greenberger, M.S.W.; Marshall S. Stanton, 
M.D.

Meeting Topic

    The Panel will hear and discuss presentations from interested 
persons regarding electrostimulation for the treatment of wounds the 
first day and sacral nerve stimulation for the treatment of refractory 
urinary urge incontinence and refractory urgency-frequency syndrome in 
adults the second day.

Procedure and Agenda

    This meeting is open to the public. The panel will hear oral 
presentations from the public for approximately 2.5 hours each day of 
the meeting. The Panel may limit the number and duration of oral 
presentations to the time available. If you wish to make formal 
presentations, you must notify the For Further Information Contact 
person, and submit the following by the Deadline for Presentations and 
Comments date listed in the DATES section of this notice: a brief 
statement of the general nature of the evidence or arguments you wish 
to present, the names and addresses of proposed participants, and an 
estimate of the time required to make the presentation. A written copy 
of your presentation must be provided to each panel member prior to 
offering your public comments. We will request that you declare at the 
meeting whether or not you have any financial involvement with 
manufacturers of any items or services being discussed (or with their 
competitors).
    After the public presentation, we will make a presentation to the 
Panel. After our presentation, the Panel will deliberate openly on the 
topic. Interested persons may observe the deliberations, but the Panel 
will not hear further comments during this time except at the request 
of the chairperson. Each day, the Panel will allow approximately a 30-
minute open public session for any attendee to address issues specific 
to the topic. At the conclusion of each day, the members will vote and 
the Panel will make its recommendation.

    Authority: 5 U.S.C. App. 2, section 10(a)(1) and (a)(2).

(Catalog of Federal Domestic Assistance Program No. 93.774, 
Medicare--Supplementary Medical Insurance Program)
    Dated: August 29, 2000.
Jeffrey L. Kang,
Director, Office of Clinical Standards and Quality, Health Care 
Financing Administration.
[FR Doc. 00-23137 Filed 9-7-00; 8:45 am]
BILLING CODE 4120-01-P